Evolution of the Average Target: Centene Corporation

Evolution of the Target Price: Centene Corporation

Changes in Analyst Recommendations: Centene Corporation

ed8013846.aMbFFmZeJBZoqoSzdAbWygds-pXFrg9GuybFLY8Ba2A.OIiVIS8tbHRf9cveBWDujHYzyuOQ_SIPyUCIV8JVOygZhZJjXzd-VVH5xQ~ab4165176e9f56b327fac6b2a10e71d7
29/07 Centene's Strong Q2 Beat Overshadowed by Delayed Medicaid Margin Recovery, RBC Says MT
29/07 UBS Adjusts Price Target on Centene to $70 From $61, Maintains Neutral Rating MT
29/07 Jefferies & Co Adjusts Centene Price Target to $59 From $48, Maintains Hold Rating MT
29/07 Truist Lifts Price Target on Centene to $80 From $78, Keeps Buy Rating MT
29/07 Goldman Sachs Adjusts Centene Price Target to $56 From $40, Maintains Sell Rating MT
29/07 Morgan Stanley Adjusts Centene Price Target to $66 From $57, Maintains Equal Weight Rating MT
29/07 Baird Adjusts Centene Price Target to $66 From $46, Maintains Neutral Rating MT
29/07 Deutsche Bank Adjusts Centene Price Target to $85 From $80, Maintains Buy Rating MT
29/07 Analyst recommendations: Carmax, Kla Corporation, Nasdaq, Fortinet, PayPal… Zonebourse
28/07 Barclays Raises Centene Price Target to $80 From $75 MT
14/07 Truist Raises Price Target on Centene to $78 From $71, Keeps Buy Rating MT
14/07 TD Cowen Adjusts Price Target on Centene to $65 From $47, Maintains Hold Rating MT
13/07 Mizuho Adjusts Price Target on Centene to $69 From $63, Maintains Neutral Rating MT
13/07 Wells Fargo Adjusts Price Target on Centene to $69 From $56, Maintains Equalweight Rating MT
09/07 RBC Trims Price Target on Centene to $71 From $70, Maintains Sector Perform Rating MT
07/07 Cantor Fitzgerald Adjusts Centene Price Target to $75 From $60 MT
23/06 Centene's Multi-Year Recovery Underway, RBC Says MT
23/06 RBC Initiates Centene at Sector Perform With $70 Price Target MT
08/06 JPMorgan Adjusts Price Target on Centene to $60 From $52, Maintains Neutral Rating MT
04/06 UnitedHealth, CVS, Cigna Seen Benefiting From Utilization Trends, AI Upside, Morgan Stanley Says MT
04/06 Morgan Stanley Raises Price Target on Centene to $57 From $50, Keeps Equalweight Rating MT
04/06 Morgan Stanley Adjusts Price Target on Centene to $57 From $50, Maintains Equalweight Rating MT
01/06 Truist Raises Price Target on Centene to $71 From $58, Keeps Buy Rating MT
27/05 Oppenheimer Adjusts Centene Price Target to $67 From $58, Maintains Outperform Rating MT
26/05 Barclays Adjusts Price Target on Centene to $75 From $63, Maintains Overweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+13.58%
+14.68%
+19.49%
+23.05%
+12.08%
+6.9%
+65.76%
+9.22%
+9.91%
+43.39%
Average +21.81%
Weighted average by Cap. +16.16%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
62.22USD
Average target price
70.67USD
Spread / Average Target
+13.58%
High Price Target
85.00USD
Spread / Highest target
+36.61%
Low Price Target
56.00USD
Spread / Lowest Target
-10.00%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
Jefferies & Co.
Truist Securities
Goldman Sachs
Morgan Stanley
Baird
Deutsche Bank Securities
Barclays
TD Cowen
Mizuho Securities
Wells Fargo Securities
RBC Capital Markets
Cantor Fitzgerald
JPMorgan Chase
Oppenheimer
BofA Securities
Bernstein
Guggenheim
Stephens Inc.
Argus
Wolfe Research
Credit Suisse
Cowen
Loop Capital
BMO Capital
Citigroup
Seaport Global Securities
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
62.22USD
Average target price
70.67USD
Spread / Average Target
+13.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CNC Stock
  4. Consensus Centene Corporation